CD22 is not only expressed on healthy or autoreactive B cells but also on the majority of B-cell lymphomas (101) and on 65% of the acute lymphoblastic leukemia (ALL) (102). Here, CD22 is linked to B-cell non-Hodgkin lymphoma.